MedWatch·Industry news·Business & finance·2d agoWSA chair withdraws demand for new CFO to have IPO experience: It's not decisiveWSA's CFO selection and potential IPO trajectory could affect investment, pricing power, and long-term strategy for a significant hearing industry player, with downstream effects on the market landscape audiologists operate in.
MedWatch·Industry news·Business & finance·2d agoWSA recruits new CFO from NovoRecruiting a CFO with a major pharmaceutical background suggests WS Audiology may be positioning itself for an IPO, which could reshape competitive dynamics and investment flows across the global hearing aid market.＋Save
